Moderate to severe chronic arteriolar lesions is an independent risk factor for adverse renal outcomes in IgA

Qian Wu1, Yi Chen1, Miaoying Shen1

  • 1Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.

Plos One
|April 24, 2025
PubMed

Insights

Moderate to severe chronic arteriolar lesions in IgA nephropathy patients significantly increase the risk of adverse renal outcomes. This study identified these lesions and other factors as key predictors of kidney disease progression.

Area of Science:

  • Nephrology
  • Pathology
  • Clinical Medicine

Background:

  • The prognostic significance of chronic arteriolar lesions in IgA nephropathy is debated.
  • Understanding these lesions is crucial for predicting IgA nephropathy progression.

Purpose of the Study:

  • To evaluate the predictive value of varying degrees of chronic arteriolar lesions for IgA nephropathy prognosis.
  • To identify risk factors associated with the development of these lesions.

Main Methods:

  • Retrospective analysis of 574 IgA nephropathy patients diagnosed via renal biopsy.
  • Classification of patients into four groups based on chronic arteriolar lesion severity.
  • Kaplan-Meier, Cox regression, and ROC curve analyses were employed.

Main Results:

  • Moderate to severe arteriolar lesions were associated with poorer clinical and pathological features.
  • Moderate to severe chronic arteriolar lesions, creatinine, S1, E1, T2, and C2 independently predicted adverse renal outcomes.
  • Creatinine, T2, and C2 were identified as independent risk factors for adverse outcomes in patients with moderate to severe lesions.

Conclusions:

  • Moderate to severe chronic arteriolar lesions are an independent risk factor for adverse renal outcomes in IgA nephropathy.
  • These findings highlight the importance of assessing arteriolar lesions for patient prognosis.
Abstract

Related Concept Videos

Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
440
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
30
Renal Corpuscle01:20

Renal Corpuscle

The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
1.2K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
305
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
376
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
530